Magnetic Resonance Spectroscopy (in vivo 1H MRS) in Clinical Neurology

Z.Z. Rozhkova, O.K. Kul’chitsky

Abstract


Based on authors’ data, obtained by in vivo 1H MRS examinations of the patients in the norm and under central nervous system pathology, various applications of this method in clinical neurology are analyzed. The new quantitative approach to the analysis of the in vivo 1Н МRS data is offered. The quantitative criteria for the evaluation of the pathological changes in cerebral metabolism caused by congenital cerebral metabolic diseases, demyelinating disorders, intra- and extra cerebral neoplasms, and various neurodegenerative disorders are formulated.


Keywords


brain; in vivo 1H MRS; neurodegenerative diseases; intracerebral neoplasms; multiple sclerosis; congenital cerebral metabolic diseases

References


Frahm J., Merboldt K.D., Haenicke W. Localized proton spectroscopy using stimulated echoes // J. Magn. Reson. — 1987. — № 72(3). — ​Р. 502-508.

Bruhn H., Frahm J., Gyndel M.L., Merboldt K.D., Haenicke W., Sauter R. Cerebral metabolism in man after acute stroke: new observations using localized proton NMR spectroscopy // Magn. Reson. Med. — 1989. — № 9(1). — ​Р. 126-131.

Arnold D.L., Matthews P.M., Francis G., Antel J. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease // Magn. Reson. Med. — 1990. — № 14(1). — ​Р. 154-159.

Bruhn H., Frahm J., Gyndel M.L. et al. Noninvasive differentiation of tumors with use the localized 1H MR spectroscopy in vivo: initial experience in patients with cerebral tumors // Radio­logy. — 1980. — № 172(2). — ​Р. 541-548.

Markus K.J., Astrakas L.G., Zurakowski D. et al. Predicting survival of children with CNS tumors using proton magnetic resonance spectroscopic imaging biomarkers // Int. J. Oncol. — 2007. — № 30. — ​Р. 651-657.

Seymour Z.A., Panigrahy A., Finlay J.L. et al. Citrate in pediatric brain with CNS tumors using proton imaging biomarkers // AJNR. — 2008. — № 29. — ​Р. 1006-1011.

De Graaf R.A. In vivo NMR Spectroscopy: principles and techniques. — 2nd ed. — ​Hoboken, Wiley, 2007.

Gupta B.K. Magnetic resonance spectroscopy in intracranial infection / Gillard J.H., Waldman A.D., Barker P.B. // Clinical MR Neuroimaging. — 2nd ed. — ​London, Cambridge University Press, 2010. — ​P. 426-454.

Oz G., Tkac I., Charnas et al. Assessment of adrenoleukodystrophy lesions by high field MRS in nonsedated pediatric patients // Neurology. — 2005. — № 64(3). — ​Р. 434-441.

Oakden W.K., Nosewortly M.D., Propylene glycol is essential in the LCmodel basis set for pediatric 1H MRS // J. Comput. Assist. Tomogr. — 2005. — № 29(1). — ​Р. 136-139.

Fein G., Meyerhald D.J., Ethanol in human brain by magnetic resonance spectroscopy: correlation with blood and breath levels, relaxation, and magnetization transfer // Alcohol. Clin. Exp. Res. — 2000. — № 24(8). — ​Р. 1227-1235.

Deelchand D.K., van de Moortelle P.F., Adriany G. et al. In vivo 1H MRS of the human brain at 9.4 T: initial results // J. Magn. Res. — 2010. — № 206(1). — ​Р. 74-80.

Marjanska M., Auerbach E.J., Valabregue R. et al. Localized 1H NMR spectroscopy in different regions of human brain in vivo at 7T: T2 relaxation times and concentrations of cerebral metabolites // NMR Biomed. — 2012. — № 25(2). — ​Р. 332-339.

Moffet J.R., Namboodiri M.A., Cangro C.B., Neale J.H. Immunohistohemical localization of NAA in rat brain // Neuroreport. — 1991. — № 2(3). — ​Р. 131-134.

Rigotti D.J., Inglese M., Gonen O. Whole brain NAA as a surrogate marker of neuronal damage in diffuse neurologic disorders // AJNR. — 2007. — № 28(10). — Р. 1843-1849.

Pouwels P.J., Kruse B., Korenke G.C. et al. Quantitative proton magnetic resonance spectroscopy of childhood adrenoleukodystrophy // Neuropediatrics. — 1998. — № 29(950). — ​Р. 254-264.

Licata S.C., Renshaw P.F. Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction // Ann. N.Y. Acad. Sci. — 2010. — № 1187. — ​Р. 148-171.

Howe F.A., Barton S.J., Gudlip S.A. et al. Metabolic profiles of human brain tumors using quantitative in vivo 1H MRS // Magn. Reson. Med. — 2003. — № 49(2). — ​Р. 223-232.

Hourani R., Brant I.J., Rizk T. et al. Can proton MR spectroscopic and perfusion imaging differentiate between neoplastic and nonneoplastic brain lesions in adults // AJNR. — 2008. — № 29(2). — ​Р. 366-372.

Garcia-Gomez J.M., Luts J., Julia-Sape M. et al. Multiproject-multicenter evaluation of automatic brain tumor classification by magnetic resonance spectroscopy // MAGMA. — 2009. — № 22(1). — ​Р. 5-18.

Vicente J., Fuster-Garcia E., Tortagada S. et al. Accurate classification of childhood brain tumors by in vivo 1H MRS multi-center study // Eur. J. Cancer. — 2013. — № 49(3). — ​Р. 658-667.

Julia Sape M., Coronel I., Majos C. et al. Prospective diagnostic performance evaluation of single-voxel 1H MRS for typing and grading of brain tumors // NMR Biomed. — 2012. — № 25(4). — ​Р. 661-673.

Growford K.S., Khayal I.S., McGue et al. Relationship of pre-surgery metabolic and physiological MRI parameters to survival for patients with untreated GBM // J. Neurooncol. — 2009. — № 91(3). — ​Р. 337-350.

Davies N.P., Wilson M., Natarajan K. et al. Non-invasive detection of glycine as a biomarker of malignancy in childhood brain tumors using in-vivo 1H MRS at 1.5 T confirmed by ex-vivo high-resolution magic angle spinning NMR // NMR Biomed. — 2010. — № 23(1). — ​Р. 80-87.

Chang S.M., Nelson S., Vanderberg S. et al. Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma // J. Neurooncol. — 2009. — № 92(3). — ​Р. 401-413.

Wijnen J.P., Idema A.J., Stawicki M. et al. Quantitative short echo time 1H MRSI of the peripheral edematous region of human brain tumors in the differentiation between glioblastoma, metastasis, and meningeoma // J. Magn. Reson. Imaging. — 2012. — № 36(2). — ​Р. 1072-1082.

Blueml S., Panigrahy A., Laskov M. et al. Elevated citrate in pediatric astrocytomas with malignant progression // Neurooncol. — 2011. — № 13(10). — ​Р. 1007-1017.

Wilson M., Gummins C.L., Macpherson L. et al. Magnetic resonance spectroscopy metabolite profiles predict survival in pediatric brain tumors // Eur. J. Cancer. — 2013. — № 49(2). — ​Р. 457-464.

Huppi P.S., Posse S., Lazeyras F. et al. Magnetic resonance in preterm and term newborns: 1H spectroscopy in developing human brain // Ped. Research. — 1991. — № 30(6). — ​Р. 574-578.

Lodygensky G.A., Menache C.C., Huppi P.S. Magnetic resonance imaging’s role in the care of the infant at risk for brain injury // Neurology: neonatology questions and controversies / Perelman J.M. — 2nd ed. — ​Amsterdam, Elsevier, 2013.

Hanrahan J.D., Cox I.J., Edwards A.D. et al. Persistent increases in cerebral lactate concentration after birth asphyxia // Pediatr. Research. — 1998. — № 44(3). — ​Р. 304-311.

Engelke U., Moolenaar S., Hoenderop S. et al. Handbook of 1H NMR spectroscopy in inborn errors of metabolism: body fluid NMR spectroscopy and in vivo MR spectroscopy. — 2nd ed. — ​Heilbronn, Germany, SPS Verlagsgesellschaft, 2007.

Manley B.J., Sokol J., Cheong J.L. Intracerebral blood and MRS in neonatal nonketotic hyperglycinemia // Ped. Neurol. — 2010. — № 42(3). — ​Р. 219-222.

Wilichovski E., Pouwels P.J., Frahm J., Hanefeld F. Quantitative proton magnetic resonance spectroscopy cerebral metabolic disturbances in patients with MELAS // Neuropediatrics. — 1999. — № 30(5). — ​Р. 256-263.

Oblenbusch A., Edvardson S., Skorpen J. et al. Leukoencepha­lopathy with accumulated succinate of SDHAF1 related complex deficiency // Orphanet J. Rare. Dis. — 2012. — № 7(1). — ​Р. 69.

Austin S.J., Connelly A., Gadian D.G. et al. Localized 1H NMR spectroscopy in Canavan Disease: a report of two cases // Magn. Reson. Med. — 1991. — № 19(2). — ​Р. 439-442.

Ndika J.D., Johnston K., Barkovich J.A. et al. Developmental progress and creatine restoration upon long-term creatine supplementation of a patient with arginine: glycine aminotransferase deficiency // Mol. Genet. Metab. — 2012. — № 106(1). — ​Р. 48-54.

Van de Kamp J.M., Pouwels P.J., Aarsen F.K. et al. Long-term follow-up and treatment in nine boys with X-linked creatine transport defect // J. Inherit. Metab. Dis. — 2012. — № 35(1). — ​Р. 141-149.

Wiame E., Tyteca D., Pierrot N. et al. Molecular identification of aspartate N-acetyltransferase and its mutation in hypoacetylaspartia // Biochem. J. — 2010. — № 425(1). — ​Р. 127-136.

Davison J.E., Hendriksz C.J., Sun Y. et al. Quantitative in vivo magnetic resonance spectroscopic monitoring of neurological involvement in mucopolysaccharidosis type II (Hunter syndrome) // J. Inherit Metab. Dis. — 2010. — № 33(3). — ​Р. 395-399.

Davison J.E., Davies N.P., Wilson M. et al. MR-spectroscopy-based brain metabolite profiling in propionic academia: metabolic changes in the basal ganglia during acute decompensation and effect of liver transplantation // Orphamet. J. Rare Dis. — 2011. — № 6. — ​Р. 19.

Aaen G.S., Holshouser B.A., Sheridan C. et al. Magnetic resonance spectroscopy predict outcomes for children with nonaccidental trauma // Pediatrics. — 2010. — № 125(2). — ​Р. 295-303.

Kreis R., Arcinue E., Ernst T. et al. Hypoxic encephalopathy after near-drowing studied by quantitative 1H MRS // J. Clin. Invest. — 1996. — № 97(5). — ​Р. 1142-1154.

Bizzi A., Castelli G., Bugiani M. et al. Classification of childhood white matter disorders using proton MR spectroscopic imaging // AJNR. — 2008. — № 29(7). — ​Р. 1270-1275.

Ding A., Kohlschuetter X.Q., Bley A. et al. Long term Neuroimaging follow-up on an asymptomatic juvenile metachromatic leukodystrophy patient after hematopoetic stem cell transplantation: evidence of myelin recovery and ongoing brain maturation // Am. J. Med. Genet. — 2012. — № 158(A). — ​Р. 257-260.

Dali C., Hanson L.G., Barton N.W. et al. Brain N-acety­laspartate levels correlate with motor function in metachromatic leukodystrophy // Neurology. — 2010. — № 75(21). — ​Р. 1896-1903.

Saija B.R., Wolinsky J.S., Narayana P.A. Proton magnetic resonance spectroscopy in multiple sclerosis // Neuroimaging. — 2009. — № 19(1). — ​Р. 45-58.

Davie C.A., Howkins C.P., Barker G.J. et al. Detection of myelin breakdown products by proton magnetic resonance spectro­scopy // Lancet. — 1993. — № 341(8845). — ​Р. 630-631.

De Graaf W.L., Kilsdonk I.D., Lopes-Soreano A. et al. Clinical application of multi-contrast 7T MR imaging in multiple sclerosis: increased lesion detection compared to 3T confined to gray matte // Eur. Radiol. — 2013. — № 23(2). — ​Р. 528-540.

Bizzi A., Ulug A.M., Crawford T.O. et al. Quantitative proton MR spectroscopic imaging in acute disseminated encephalomyetis // AJNR. — 2001. — № 22(6). — ​Р. 1125-1130.

De Stefano N., Filippi M., Mueller D. et al. Guedelines for using proton MR spectroscopy in multicenter clinical MS studies // Neurology. — 2007. — № 69(20). — ​Р. 1942-1952.

Agarwal M., Chawla S., Husain N. et al. Higher succinate than acetate levels differentiate cerebral degenerating cysticerci from anaerobic abscesses on in vivo proton MR spectroscopy // Neuroradiology. — 2004. — № 75(19). — ​Р. 211-215.

Kantarchi K., Lowe V., Przybelski S.A. et al. Magnetic Resonance Spectroscopy, beta-amyloid load, and cognition in a population-based sample of cognitively normal older adults // Neurology. — 2011. — № 77. — ​Р. 951-958.

Modrego P.J., Fayed N., Sarasa M. Magnetic Resonance Spectroscopy in prediction of early conversion from amnestic and mild cognitive impairment to dementia: a prospective cohort study // BMJ Open. — 2011. — № 1.

Walecki J., Barcikowska M., Cvika J.B., Gabrielewicz T. NAA, Cho, mIns, Glx concentration changes in proton MR spectro­scopy (1H MRS) in patients with mild cognitive impairment (MCI) // Med. Sci. Monit. — 2011. — № 17. — ​Р. 105-111.

Penner J., Rupsingh, Smith M. et al. Increased glutamate in the hippocampus after galantamine treatment for Alzheimer Dise­ase // Prog. Neuropsychopharmacol. Biol. Psychiatry. — 2010. — № 34(1). — ​Р. 104-110.

Rupsingh R., Borrie M., Smith M. et al. Reduced hippocampal glutamine in Alzheimer disease // Neurobiol. Aging. — 2011. — № 32(5). — ​Р. 802-810.

Griffith H.R., Stewart C.C., den Hollander J.A. Proton magnetic resonance spectroscopy in dementians and mild cognitive impairment // Int. Rev. Neurobiol. — 2009. — № 84. — ​Р. 105-131.

Godbolt A.K., Waldman A.D., MacManus D.G. et al. MRS shows abnormalitiaes before symptoms in familian Alzheimer disease // Neurology. — 2006. — № 66(5). — ​Р. 718-722.

Kantarci K., Boeve B.F., Wazolek Z.K. et al. MRS in presymptomatic MAPT mutation carriers: a potential biomarker for taumediated pathology // Neurology. — 2010. — № 75(9). — ​Р. 771-778.

Englot D.J., Wang D.D., Rolston J.D. et al. Rates and predictors of longterm seizure freedom after frontal lobe epilepsy surgery: a systematic review and meta-analysis // J. Neurosurg. — 2012. — № 116(5). — ​Р. 1042-1048.

Fountas K.N., Tsougos I., Cotsis E.D. et al. Temporal pole proton preoperative magnetic resonance spectroscopy in patients undergoing surgery for mesial temporal sclerosis // Neurosurg. Focus. — 2012. — № 32(3). — ​E3.

Pen J.W., Duckrow R.B., Spencer D.D. et al. Selective homonuclear polarization transfer for spectroscopic imaging of GABA at 7T // Magn. Reson. Med. — 2013. — № 69(2). — ​Р. 310-316.

Gonzalez B.G. Clinical MRI of acute ischemic stroke // J. Magn. Reson. Imaging. — 2012. — № 36(2). — ​Р. 259-271.

Рожкова З.З. 1H in vivo для установления связи между локальным состоянием головного мозга человека и магнитно-резонансными характеристиками церебральных метаболитов: Дис… канд. физ.-мат. наук, 2005.

Prowencher S.W. Automatic quantification of localized in vivo 1H spectra with LCModel // NMR Biomed. — 2001. — № 14(4). — ​Р. 260-264.

Scheidegger O., Wingeier K., Stefan D. et al. Optimized quantitative magnetic resonance spectroscopy for clinical routine // Magn. Reson. Med. — 2013. — № 70(1). — ​Р. 25-32.

Somorjai R.L. Creating robust, reliable, clinically relevant classifiers from spectroscopic data // Biophys. Rev. — 2009. — № 1(4). — ​Р. 201-211.




DOI: https://doi.org/10.22141/2224-0713.5.83.2016.78468

Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 INTERNATIONAL NEUROLOGICAL JOURNAL

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru